Biolojic Design Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 69

Employees

  • Latest Deal Type
  • Debt

  • Latest Deal Amount
  • $1.25M

  • Investors
  • 4

Biolojic Design General Information

Description

Developer of a computational biology and artificial intelligence platform designed to transform antibodies into intelligent medicines. The company's platform offers machine learning, multibody capability, epitope-specific engineering, programmable functional switches, multispecific symmetrical IgG, and logic gate execution, enabling biopharmaceutical companies to program antibodies to adapt to changing biological situations.

Contact Information

Website
biolojic.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Hamada street 12
  • Post Office Box 80
  • Rehovot 7670316
  • Israel
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Biotechnology
Corporate Office
  • Hamada street 12
  • Post Office Box 80
  • Rehovot 7670316
  • Israel

Biolojic Design Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biolojic Design Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Debt - General 30-Jun-2025 $1.25M Completed Generating Revenue
7. Debt - General 31-Mar-2025 Completed Generating Revenue
6. Debt - General 30-Jun-2023 Completed Generating Revenue
5. Later Stage VC 01-Jan-2023 Completed Clinical Trials - Phase 1
4. Secondary Transaction - Private Completed Clinical Trials - Phase 1
3. Equity Crowdfunding 12-Jan-2021 Completed Clinical Trials - Phase 1
2. Later Stage VC (Series A) 02-Jul-2018 $11M $15.2M Completed Clinical Trials - Phase 1
1. Angel (individual) 27-Aug-2014 $4.15M $4.15M Completed Pre-Clinical Trials
To view Biolojic Design’s complete valuation and funding history, request access »

Biolojic Design Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preferred B
Preferred A1
Preferred A 13,000 $0.010000 $83.21 $83.21 1x $83.21 10.44%
To view Biolojic Design’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Biolojic Design Patents

Biolojic Design Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025253250-A1 Engineered trop2/nectin4 dual binding antibodies and uses thereof Pending 02-Jun-2024
WO-2025250701-A1 Anti-tumor necrosis factor receptor 2 (tnfr2) antibodies and methods of use Pending 28-May-2024
US-20260132195-A1 Anti-il-2 antibody combinations and methods of use thereof Pending 04-Jan-2024
US-20260183390-A1 Anti-il-2 antibody combinations and methods of use thereof Pending 10-Nov-2022
US-20260207741-A1 Anti-il-2 antibody combinations and methods of use thereof Pending 10-Nov-2022 A61K39/3955
To view Biolojic Design’s complete patent history, request access »

Biolojic Design Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biolojic Design Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Western Technology Investment Venture Capital Minority
aMoon Fund Venture Capital Minority
OurCrowd Venture Capital Minority
Angel (individual) Minority
To view Biolojic Design’s complete investors history, request access »

Biolojic Design Investments (1)

Biolojic Design’s most recent deal was a Early Stage VC with Aulos for . The deal was made on 10-Aug-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Aulos 10-Aug-2023 Early Stage VC Drug Discovery
To view Biolojic Design’s complete investments history, request access »

Biolojic Design FAQs

  • When was Biolojic Design founded?

    Biolojic Design was founded in 2009.

  • Where is Biolojic Design headquartered?

    Biolojic Design is headquartered in Rehovot, Israel.

  • What is the size of Biolojic Design?

    Biolojic Design has 69 total employees.

  • What industry is Biolojic Design in?

    Biolojic Design’s primary industry is Drug Discovery.

  • Is Biolojic Design a private or public company?

    Biolojic Design is a Private company.

  • What is Biolojic Design’s current revenue?

    The current revenue for Biolojic Design is .

  • How much funding has Biolojic Design raised over time?

    Biolojic Design has raised $32.8M.

  • Who are Biolojic Design’s investors?

    Western Technology Investment, aMoon Fund, OurCrowd, and have invested in Biolojic Design.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process